Its benefits include reducing local inflammation and oxidative damage, and improving subjective pain perception

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been linked with behavioral side effects. A large population-based analysis in Diabetes, Obesity and Metabolism assessed whether certain genetic variants might help explain these effects.

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in Otolaryngology–Head and Neck Surgery reveals that for people with sleep apnea, getting surgery for their condition may lessen their risk of such accidents compared with using a CPAP device at night or receiving no treatment.

A recent first-of-its-kind study conducted by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) found that mislabelled NSAID (Non-Steroidal Anti-Inflammatory Drug) allergies for stroke patients hinders the use of effective medications for them, leading to poorer treatment outcomes. It also revealed that when stroke survivors with NSAID allergy labels underwent testing, 80% were found to be mislabelled. The research highlights the significant impact of mislabelling on patient care and outcomes, emphasising the urgent need for thorough evaluation and management of drug allergies. The findings were published in the international journal Stroke [link to publication].